Dr. Preetham Dev - SPARSH Hospital
Contact Request for Callback

Dr. Preetham Dev

Consultant Urologist and Renal Transplant Surgeon

Qualification:

MBBS, MS (General Surgery), MCh (Urology), DNB (Urology), FMAS, Fellowship in Robotic Surgery and Uro-Oncology

Specialities:

Organ Transplant

Renal Sciences

Robotic Surgery

Urology

Da Vinci Robotic System

Renal Transplant

Oncology

Location:

SPARSH Hospital, Yelahanka

Book an Appointment

Dr. Preetham Dev is available for appointments. Please fill the below form to book an appointment.

Dr. Preetham Dev, a highly qualified Consultant in Urology, boasts of an impressive array of qualifications and memberships. His educational journey includes MBBS, MS in General Surgery, MCh in Urology, and DNB in Urology. Dr. Dev has also earned additional certifications, such as FMAS and a Fellowship in Robotic Surgery and Uro-Oncology from the Vattikuti Foundation in MI, USA.

Dr. Preetham Dev’s field of expertise covers a wide spectrum, including endo-urological and laser surgery for stone disease, endo-urological and minimal invasive surgery for prostate disease, complex urology and uro-oncology surgeries, and urology reconstructive surgeries.

Dr. Dev’s commitment to advancing knowledge is evident in his contributions to research and academic discourse. He has participated in ICMR Short Term Studentship, authored research papers, and delivered talks on various urological topics.

Dr. Preetham Dev has published research articles in reputable journals on subjects ranging from the feasibility of short-term studentships to the safety and efficacy of certain urological procedures. Notable publications include studies on dilatation in percutaneous nephrolithotomy, robot-assisted-Video Endoscopic Inguinal Lymphadenectomy, and the comparative analysis of treatments for Non-Muscle Invasive Bladder Cancer.

His research extends to investigating the safety of uro-oncology practices and robot-assisted surgery during the peak of the COVID-19 pandemic, as well as comparing adverse effects, short-term outcomes, and cost implications of different treatments for Non-Muscle Invasive Bladder Cancer.

In summary, Dr. Preetham Dev emerges as a distinguished Consultant in Urology with a rich academic background, diverse expertise in urological procedures, extensive research contributions, and a commitment to the ongoing advancement of medical knowledge in the field of urology.

Affiliations
  • Karnataka Medical Council, Karnataka
  • Urological Society of India, Associate Member
  • Association of Southern Urologist (South Zone †USI)
  • Karnataka Urology Association †P036A. European Association of Urology
  • American Association of Urology
  • Societe Internationale d’Urologie
  • Robotic Urology Forum of India

Publications
  • ICMR- Short Term Studentship 2006: Effect of dutasteride in reducing bleeding during TURP, under the guidance of Dr. Nagaraja N H, Prof. Dept of Urology, INU, Bangalore.
  • Tubercular mastitis, an uncommon entity of the common disease: A case report. Journal of Evolution of Medical and Dental Sciences 2014; Vol. 3, Issue 10, March 10; page: 2408-2412, DOI: 10.14260/jemds/2014/2152.
  • Single-step dilatation in percutaneous nephrolithotomy, its safety and efficacy: A prospective, single-centre study Urology Annals 2019 Apr-Jun; 11(2):171-174. doi: 10.4103/UA.UA_43_18.
  • Great Saphenous Vein Sparing Robot Assisted-Video Endoscopic Inguinal Lymphadenectomy (SVS-RVEIL) for Carcinoma of Penis- Video Demonstration. Journal of Endourology (Part B. Videourology). DOI:10.1089/vid.2020.0077.
  • Comparative study of perioperative and survival outcomes after Video Endoscopic Inguinal Lymphadenectomy (VEIL) and Open Inguinal Lymph Node Dissection (O-ILND) in the management of inguinal lymph nodes in carcinoma of the penis. Journal of Robotic Surgery. DOI: 10.1007/s11701- 020-01189-x.
  • Intravesical bacillus Calmette-Guerin (BCG) in treating Non-Muscle Invasive Bladder Cancer- Analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow). Asian Journal of Urology. https://doi.org/10.1016/j.ajur.2021.05.002
  • Safety of Uro-Oncology practice and Robot-assisted Surgery during the peak of COVID-19 Pandemic: A Report from India. Accepted for publication in the Journal of Cancer Research and Therapeutics. DOI: 10.4103/jcrt.JCRT_1006_20.
  • Comparing adverse effects, short-term outcomes, and cost implications of Hyperthermic Intravesical Chemotherapy (HIVEC) with mitomycin and intravesical bacillus Calmette-Guerin (BCG) instillation (Moscow-I strain) in the management of intermediate and high-risk Non-Muscle Invasive Bladder Cancer (NMIBC)- An Indian Experience. Under Peer Review in Urology Annals. Manuscript number: UA_139_20.
  • Perioperative, functional, quality of life, and oncological outcomes after robot-assisted radical cystectomy and intra-corporeal orthotopic ileal neobladder – Our experience. Under Peer review in the Indian Journal of Surgical Oncology. Manuscript No: IJSO-D-21-00037.
  • Right Renal Cell Carcinoma with Solitary, Contralateral Adrenal Metastasis with Adrenal Vein and Renal Vein Tumor Thrombus: A Case Report. Under peer review in Journal of Clinical Urology. Manuscript No: URO-20-0184.
  • Robotic Freyerâs prostatectomy: Operative technique and single-centre experience †Observational study. Submitted in Journal of Robotic Surgery. Manuscript No: JORS-D-21-00023

Qualifications
  • MBBS – Bangalore Medical College and Research Institute
  • MS (General Surgery) – JSS Medical College, Mysore
  • MCh (Urology) – JSS Medical College, Mysore
  • DNB (Urology)
  • FMAS
  • Fellowship in Robotic Surgery and Uro-Oncology – Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute

Our Doctors

Unlock the door to exceptional healthcare, book an appointment with SPARSH Hospital and let your journey to wellness begin.